Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Gastrointestinal Diseases"
Show Display Options
Rank Status Study
1 Not yet recruiting Fructose Breath-testing in Irritable Bowel Syndrome (IBS)
Conditions: Functional Gastrointestinal Disorders;   Irritable Bowel Syndrome
Interventions: Procedure: Open breath test with fructose;   Procedure: Breath test with sweet placebo (Assugrin);   Procedure: Breath test with neutral placebo (still water);   Procedure: Blinded breath test with fructose
2 Recruiting Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study
Conditions: Liver Failure;   Carcinoma, Hepatocellular
Interventions: Procedure: Remote Ischemic Conditioning (RIC);   Device: Pneumatic tourniquet
3 Unknown  Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
Condition: Portal Hypertension Related to Cirrhosis
Interventions: Drug: Carvedilol;   Procedure: Variceal band ligation
4 Recruiting HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
Condition: Hepatocellular Carcinoma
Interventions: Device: HepaSphere/QuadraSphere Microspheres;   Procedure: PVA, lipiodol, doxorubicin
5 Recruiting Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Conditions: Pancreatic Acinar Cell Carcinoma;   Pancreatic Ductal Adenocarcinoma;   Pancreatic Intraductal Papillary-Mucinous Neoplasm;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Drug: Capecitabine;   Drug: Chemotherapy;   Drug: Erlotinib Hydrochloride;   Drug: Fluorouracil;   Drug: Gemcitabine Hydrochloride;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
6 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)
7 Recruiting Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Condition: Non Alcoholic Steatohepatitis (NASH)
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
8 Recruiting Mobilization of Mesenchymal Stem Cells During Liver Transplantation
Conditions: Liver Failure;   Liver Neoplasm
Intervention: Procedure: blood samples

Indicates status has not been verified in more than two years